Seasonal Administration of Omalizumab in Patients With Uncontrolled Asthma and Sensitization to Olive Pollen

J Investig Allergol Clin Immunol. 2021 Oct 25;31(5):436-438. doi: 10.18176/jiaci.0657. Epub 2020 Nov 25.

Authors

P Serrano^{1

2

3}, A Navas^{1

2

3}, B Ruiz-León^{1

2

3}, L Herrero⁴, C Rondón^{3

5}, A Jurado^{1

2

3}, C Moreno-Aguilar^{1

2

3}

Affiliations

¹ Department of Immunology and Allergy, Reina Sofia University Hospital, Córdoba, Spain.
² Maimonides Biomedical Research Institute of Córdoba (IMIBIC)/ Reina Sofia University Hospital/University of Córdoba, Córdoba, Spain.
³ National Network ARADyAL, Carlos III Health Institute, Madrid, Spain.
⁴ Department of Information, Computer Systems and Archives Systems (Contabilidad Analítica), Hospital Infanta Margarita, Cabra, Córdoba, Spain.
⁵ Biomedical Research Institute of Málaga (IBIMA)/Allergy Unit Hospital Regional Universitario de Málaga, Málaga, Spain.

PMID: 33237024
DOI: 10.18176/jiaci.0657

No abstract available

Keywords: Asthma; Olive pollen; Omalizumab; Seasonal.

MeSH terms

Asthma* / drug therapy
Humans
Olea*
Omalizumab / therapeutic use
Pollen
Seasons

Substances

Omalizumab